GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Genesystem Co Ltd (XKRX:363250) » Definitions » Pretax Margin %

Genesystem Co (XKRX:363250) Pretax Margin % : -1,760.12% (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Genesystem Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Genesystem Co's Pre-Tax Income for the three months ended in Mar. 2024 was ₩-2,379.9 Mil. Genesystem Co's Revenue for the three months ended in Mar. 2024 was ₩135.2 Mil. Therefore, Genesystem Co's pretax margin for the quarter that ended in Mar. 2024 was -1,760.12%.

The historical rank and industry rank for Genesystem Co's Pretax Margin % or its related term are showing as below:

XKRX:363250' s Pretax Margin % Range Over the Past 10 Years
Min: -1449.63   Med: -193.26   Max: 23.91
Current: -1449.63


XKRX:363250's Pretax Margin % is ranked worse than
92.76% of 221 companies
in the Medical Diagnostics & Research industry
Industry Median: -13.24 vs XKRX:363250: -1449.63

Genesystem Co Pretax Margin % Historical Data

The historical data trend for Genesystem Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genesystem Co Pretax Margin % Chart

Genesystem Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Pretax Margin %
-356.08 -27.09 23.91 -193.26 -882.09

Genesystem Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -461.62 -1,245.40 -1,119.62 -2,306.57 -1,760.12

Competitive Comparison of Genesystem Co's Pretax Margin %

For the Diagnostics & Research subindustry, Genesystem Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Genesystem Co's Pretax Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Genesystem Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Genesystem Co's Pretax Margin % falls into.



Genesystem Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Genesystem Co's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin=Pre-Tax Income (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=-7912.6/897.028
=-882.09 %

Genesystem Co's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-2379.857/135.21
=-1,760.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genesystem Co  (XKRX:363250) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


Genesystem Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Genesystem Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Genesystem Co (XKRX:363250) Business Description

Traded in Other Exchanges
N/A
Address
200-9, Techno 2-ro, Yuseong-gu, Daejeon, KOR, 34028
Genesystem Co Ltd is a biotech engineering company specializing in molecular testing solutions that target on-site testing needs. It develops and markets state-of-the-art PCR platforms as well as related reagents and biochip products designed to enhance the health of human societies and improve the quality of human life.

Genesystem Co (XKRX:363250) Headlines

No Headlines